SEARCH
Quotes News NAV
Profit & Loss Markets  >  Corporate Information  >   Profit & Loss
Senores Pharmaceuticals Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544319 INE0RB801010 155.0571017 SENORES 0 3,779.85 309.72 2.65 10
     ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
INCOME :     
Sales Turnover 38.5434.0112.3813.547.91
Excise Duty0.000.000.000.000.00
Net Sales38.5434.0112.3813.547.91
Other Income 21.996.846.790.940.15
Stock Adjustments 4.100.390.482.40-0.05
Total Income64.6341.2419.6516.888.01
EXPENDITURE :     
Raw Materials 14.6714.086.3510.603.94
Power & Fuel Cost0.440.310.000.000.03
Employee Cost 18.259.355.022.861.63
Other Manufacturing Expenses 9.326.890.050.040.76
Selling & Administrative Expenses 7.193.792.961.280.35
Miscellaneous Expenses 0.050.040.260.000.14
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.00
Total Expenditure49.9234.4614.6514.796.84
Operating Profit14.716.785.012.101.17
Interest 6.522.712.140.560.20
Gross Profit8.194.072.871.540.97
Depreciation3.082.040.930.710.57
Profit Before Tax5.112.031.940.830.40
Tax1.451.360.350.170.01
Fringe Benefit tax0.000.000.000.000.00
Deferred Tax-0.03-0.140.39-0.02-0.45
Reported Net Profit3.690.811.200.680.84
Extraordinary Items 0.000.000.000.000.00
Adjusted Net Profit3.690.811.200.680.84
Adjustment below Net Profit 0.010.010.000.000.00
P & L Balance brought forward3.392.571.370.690.34
Statutory Appropriations0.000.000.000.000.00
Appropriations 0.000.000.000.000.00
P & L Balance carried down7.093.392.571.371.18
Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Equity Dividend %0.000.000.000.000.00
Dividend Per Share(Rs)0.000.000.000.000.00
Earnings Per Share-Unit Curr0.800.271.220.782.20
Earnings Per Share(Adj)-Unit Curr0.800.271.220.782.20
Book Value-Unit Curr153.7455.1039.6638.5424.91
Book Value(Adj)-Unit Curr153.7455.1039.6638.5424.91